Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Romana Mauro

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
The Lancet. Haematology|April 2, 2025
Improving SARS-CoV-2 vaccine response is challenging in chronic lymphocytic leukaemiaFrancesca Romana Mauro
Expert Review of Anticancer Therapy|July 12, 2024
The new life of ibrutinib therapy in CLL: enhancing personalized approachesStefano Molica, Francesca Romana Mauro
Blood|April 21, 2018
Gene mutations in lenalidomide-treated CLLFrancesca Romana Mauro, Robin Foà
Leukemia & Lymphoma|July 22, 2011
Chronic lymphocytic leukemia in less fit patients: "slow-go"Ilaria Del Giudice, Francesca Romana Mauro, Robin Foà
Current Opinion in Oncology|October 15, 2005
New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemiaMassimo Gentile, Francesca Romana Mauro, Anna Guarini, et al.
Cancer Research|August 9, 2003
The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell responseEnrica Orsini, Anna Guarini, Sabina Chiaretti, et al.
Cancers|June 19, 2024
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted AgentsAndrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Critical Reviews in Oncology/Hematology|November 23, 2025
Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemiaAndrea Visentin, Alessandro Cellini, Francesco Angotzi, et al.
Leukemia & Lymphoma|February 17, 2012
Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implicationsStefano Molica, Francesca Romana Mauro, Matteo Molica, et al.
Frontiers in Oncology|January 26, 2026
Prognostic factors associated with recurrent COVID-19 and impact of SARS-CoV-2 vaccine on patients with chronic lymphocytic leukemiaSara Pepe, Roberta Mazzarella, Costanza Andriola, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
The Lancet. Haematology|April 2, 2025
Improving SARS-CoV-2 vaccine response is challenging in chronic lymphocytic leukaemiaFrancesca Romana Mauro
Expert Review of Anticancer Therapy|July 12, 2024
The new life of ibrutinib therapy in CLL: enhancing personalized approachesStefano Molica, Francesca Romana Mauro
Blood|April 21, 2018
Gene mutations in lenalidomide-treated CLLFrancesca Romana Mauro, Robin Foà
Leukemia & Lymphoma|July 22, 2011
Chronic lymphocytic leukemia in less fit patients: "slow-go"Ilaria Del Giudice, Francesca Romana Mauro, Robin Foà
Current Opinion in Oncology|October 15, 2005
New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemiaMassimo Gentile, Francesca Romana Mauro, Anna Guarini, et al.
Cancer Research|August 9, 2003
The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell responseEnrica Orsini, Anna Guarini, Sabina Chiaretti, et al.
Cancers|June 19, 2024
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted AgentsAndrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Critical Reviews in Oncology/Hematology|November 23, 2025
Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemiaAndrea Visentin, Alessandro Cellini, Francesco Angotzi, et al.
Leukemia & Lymphoma|February 17, 2012
Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implicationsStefano Molica, Francesca Romana Mauro, Matteo Molica, et al.
Frontiers in Oncology|January 26, 2026
Prognostic factors associated with recurrent COVID-19 and impact of SARS-CoV-2 vaccine on patients with chronic lymphocytic leukemiaSara Pepe, Roberta Mazzarella, Costanza Andriola, et al.
Pageof 12